Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial

Abstract

Zinc monotherapy improves mood in overweight or obese subjects most likely through increasing BDNF levels.